To determine the effect and safety of continuous glucose monitoring (CGM) use in glycemic control compared to standard approach in hospitalized patients with type 2 diabetes.
MOBILE APP Developed specifically for the ADA’s 85th Scientific Sessions, the coordinating mobile event app and Online Planner are your go-to meeting resources with details…
EASD will hold its 31st Scientists Training Course in Barcelona, Catalonia, Spain from 10 -14 November 2025, with the objective of promoting new talents in…
CHICAGO — A once-weekly basal insulin conferred similar HbA1c to once-daily insulins among adults with type 2 diabetes, both in previous basal insulin users and…
CHICAGO — Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared with women who continued drinking…
A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%.
CHICAGO — An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with population-wide weight loss, researchers reported at…
CHICAGO — Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the…
A leading scholar in epidemiology and health equity, Tiffany L. Gary-Webb, PhD, MHS, will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes…
Panelists, including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.
“Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have spoken on this matter, this…
